Research map: Bepirovirsen induces innate immune proteins independent of HBV

Back to the article

Papers in this map

  1. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Yoav Benjamini · 1995 · 112507 citations · Cited by this paper
  2. Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease · 2026 · Related
  3. limma powers differential expression analyses for RNA-sequencing and microarray studies · Matthew E. Ritchie · 2015 · 44581 citations · Cited by this paper
  4. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update · 2026 · Related
  5. The Chemokine System in Innate Immunity · Caroline L. Sokol · 2015 · 913 citations · Cited by this paper
  6. APASL STC on Wilson Disease; New Delhi 2026 · 2026 · Related
  7. Therapeutic strategies for hepatitis B virus infection: towards a cure · Gregory C. Fanning · 2019 · 584 citations · Cited by this paper
  8. Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial · 2026 · Related
  9. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions · Pieter Ruytinx · 2018 · 475 citations · Cited by this paper
  10. Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study · 2026 · Related
  11. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection · Markus Cornberg · 2025 · 420 citations · Cited by this paper
  12. Precision medicine for G-CSF in ACLF: the biomarker gap · 2026 · Related
  13. The interaction of innate immune and adaptive immune system · Ruyuan Wang · 2024 · 299 citations · Cited by this paper
  14. Response to letter to editor—Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · 2026 · Related
  15. Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection · Man‐Fung Yuen · 2022 · 277 citations · Cited by this paper
  16. Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment · 2026 · Related
  17. Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial · Man‐Fung Yuen · 2021 · 159 citations · Cited by this paper
  18. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference · Marc G. Ghany · 2023 · 123 citations · Cited by this paper
  19. Consider the chemokines: a review of the interplay between chemokines and T cell subset function. · Marianne Strazza · 2017 · 27 citations · Cited by this paper
  20. Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection · Jinlin Hou · 2026 · 23 citations · Cited by this paper
  21. The multifaceted role of XCL1 in health and disease · Muhammed Syed · 2025 · 16 citations · Cited by this paper
  22. Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study) · Shilpy Joshi · 2025 · 9 citations · Cited by this paper
  23. WED-364 High-dimensional analysis of flow cytometry data reveals differences in post-treatment frequencies of naïve B cells, CD56dim natural killer cells, and terminally differentiated effector memory CD8+ T cells in responders versus nonresponders to bepirovirsen · Thea V. Hogan · 2024 · 4 citations · Cited by this paper
  24. Bepirovirsen induces innate immune activation in the liver potentially through TLR8 signaling · Megan E. Ermler · 2026 · 3 citations · Cited by this paper
  25. A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants · Amir S. Youssef · 2025 · 1 citation · Cited by this paper
  26. Intrahepatic and peripheral immunophenotyping of participants with chronic hepatitis B receiving bepirovirsen in the B-Fine study strongly suggests that bepirovirsen may trigger a humoral response · André Boonstra · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)